FDA to Hold Webinar on the Updated “Healthy” Claim
Webinar on the Final Rule on the Definition of Term “Healthy” on food labels
Webinar on the Final Rule on the Definition of Term “Healthy” on food labels
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.), a Trop-2-directed antibody and topoisomerase inhibitor conjugate, for adult…
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.), a Trop-2-directed antibody and topoisomerase inhibitor conjugate, for adult…
Tens of billions of dollars in hospital revenue could be at stake if Medicare cuts payments for outpatient care.
Obstetrician-gynecologist Ericka Gibson, MD, MPH, of The Southeast Permanente Medical Group to join U.S. Preventive Services Task Force
Gary Nagle is facing a tricky situation. The Glencore CEO has a mix of copper mines, which everyone wants, and a giant coal business, which…
Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology
Ruchika Talwar interviews Eric Walton and Akanksha Metha about their study on the impact of legislation on access to gender-affirming care, published in the Gold…
On Jan. 15, 2025, the FDA approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for KRAS G12C-mutated metastatic colorectal cancer.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey! This is Meghana.…
California has a few major changes coming to its health policy landscape in 2025. New laws that took effect Jan. 1 ban medical debt from…